SMURF-Therapeutics, Inc.
Treatments for
cancer, anemia,
and wound healing
- Targeting achilles heal of cancer growth.
- Improving anemia and wound healing.
SMURF-Therapeutics, Inc.
SMURF-Therapeutics, Inc. is developing small molecule therapeutics to activate or block Smurf2 for cancer, anemia and wound healing. The company was founded by Wafik El-Deiry, MD, PhD, FACP in 2021 to develop small molecule compounds targeting hypoxia responses based on numerous academic research papers and reviews published over 3 decades.
OUR FOCUS
Targeting Hypoxic Responses for Patient Benefits
Treat anemia of chronic disease and myelofibrosis
Increase blood formation
Improve fatigue
For metastatic cancer
Slow tumor growth
Inhibit angiogenesis
Improve health
Get In Touch with SMURF-Therapeutics, Inc.
OUR EXPERTISE
OUR EXPERTISE
